Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Algal oil is primarily valued as a plant-based source of omega-3 fatty acids, particularly docosahexaenoic acid (DHA), and to a lesser extent eicosapentaenoic acid (EPA). Scientific interest in using algal oil to support or treat Fatty Liver Disease—specifically non-alcoholic fatty liver disease (NAFLD)—stems from evidence that omega-3 fatty acids can reduce liver fat, inflammation, and improve lipid metabolism. Several clinical trials and meta-analyses have shown that omega-3 supplementation, including algal-derived DHA and EPA, may help decrease hepatic fat accumulation and improve liver enzyme levels in patients with NAFLD.

While most studies have examined fish oil, algal oil is increasingly studied as an alternative, especially for vegetarians, vegans, or those avoiding fish due to allergies or contaminants. Some randomized controlled trials suggest that algal oil supplementation can reduce liver fat content and improve markers of liver health, though the evidence base is smaller compared to fish oil and sometimes uses relatively high doses. Algal oil is generally safe and well-tolerated.

In summary, the use of algal oil for fatty liver disease is supported by growing scientific evidence—mainly extrapolated from research on omega-3 fatty acids in general. However, more large-scale, long-term trials specifically using algal oil are needed for stronger conclusions. Its use is not based on traditional medicine but rather on modern nutritional science.

More about algal oil
More about Fatty Liver Disease

Other ingredients used for Fatty Liver Disease

Other health conditions supported by algal oil

Products containing algal oil

Metagenics OmegaGenics Algae EPA-DHA 300 mg